about
Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling PathwayDown-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway.Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non-small-cell Lung Cancer by Binding to EZH2 and Suppressing p57.The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression.Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway.miR-134: A Human Cancer Suppressor?Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer.CDK3 is a major target of miR-150 in cell proliferation and anti-cancer effect.The novel miR-9501 inhibits cell proliferation, migration and activates apoptosis in non-small cell lung cancer.Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.Red Meat Consumption and the Risk of Stroke: A Dose-Response Meta-analysis of Prospective Cohort Studies.Sirtuin 1 promotes the proliferation of C2C12 myoblast cells via the myostatin signaling pathway.MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.MiRNA-based therapeutic strategy in lung cancer.miR-206/133b Cluster: A Weapon against Lung Cancer?miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis.The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2.Echinocystic acid ameliorates hyperhomocysteinemia-induced vascular endothelial cell injury through regulating NF-κB and CYP1A1.MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.Long intergenic non-protein coding RNA 319 aggravates lung adenocarcinoma carcinogenesis by modulating miR-450b-5p/EZH2.Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-β/Smad signaling.Emerging landscape of circular RNAs in lung cancer.Long non coding RNA XIST as a prognostic cancer marker - A meta-analysis.Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2Editorial: Towards MiRNA Based Therapeutics for Lung CancerComprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast CancerLncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinomaExpression and Prognosis Analyses of Runt-Related Transcription Factor Family in Human Leukemia
P50
Q35859481-B78A5C65-3A34-471D-86DA-5973DE245865Q36413232-026C3705-FF11-4B8C-8C08-F5DFFEAC7FD0Q36946799-FE28B830-B0CE-4F98-BB75-7FE733F5349BQ37423551-A2491E1D-95C4-49EA-B4AE-DD5B737E0400Q37501589-D0492B61-FA40-47D4-8246-ECA839C57EC5Q37501595-6B7905BC-C6F6-4DF5-9F6D-5020EDB477C9Q37588369-7A1716B1-102A-48A0-8D82-931620FB4CB2Q37718061-BFFB071F-BC4D-42C7-A1C7-9253079DD0C7Q38449984-E82A7458-7F38-4695-85EC-0AE84AA373E9Q38720314-E5590BE1-A1E7-4459-AE3D-1AC01563778FQ38741464-31D62B9F-21E4-4189-A81E-02271073A8ACQ38753084-91FE6A32-D9A8-4562-A902-8D6A0A07BB52Q38758149-CC4A6312-EC7A-4A15-8A65-A28A7CF75A9FQ38765686-109A3ACD-1A81-4FF9-9CEB-7643A1B7EFC6Q38796695-5D189888-66DC-41DD-8782-8DCE9532B027Q38873260-3EAF3B63-D9FE-4B65-BFCD-F531C50B0ACAQ39459009-11338C6F-31BC-4DD0-B5CF-610155DCB92EQ41235074-6EC90E6B-6C66-4CC2-8B6B-2136CEB8CD93Q42198057-0528173D-6D50-4603-9B2B-8332609BC250Q46675216-A39A5462-0999-4F7A-8AAB-DCF702D57CEBQ47114893-62FAD40C-EF1F-4067-9F3F-B64D29C4D346Q47663124-6E0E5E09-144C-45F2-8238-09EC142D8CF0Q50165459-2581C3C9-41CB-4DFB-9CED-5AC320B122FCQ50280511-42614AAE-9B1F-4CC5-88E8-59C1DF544690Q52589675-CD6B52A8-46CE-4775-8657-E56D9377B577Q52631828-A91CFCEB-17F7-4433-9AEF-CC0125896B79Q55153270-7A4DF0B2-79CC-455F-9EFB-1EA173644DE5Q86543267-A59BA5CF-91CB-4D87-85A9-6A3917113FD1Q87918927-2BD3AC5E-484A-4A05-BE2F-EA4AF79291EEQ90211805-EE4EDA63-E757-404A-9627-EBDDBFA6A35FQ90634972-43FA4210-6AB9-4E5C-8E39-BEC6609538B3Q91343615-5E574D4A-31F6-4D5A-B2A4-C402B3EFD6BC
P50
description
investigador
@es
researcher
@en
name
Chengcao Sun
@en
type
label
Chengcao Sun
@en
prefLabel
Chengcao Sun
@en
P31
P496
0000-0002-0554-3165